Credit score: Cell Metabolism (2024). DOI: 10.1016/j.cmet.2024.11.003
Overweight mice whose fats cells have been genetically altered to provide an elevated quantity of the glucose-dependent insulinotropic polypeptide receptor (GIPR) misplaced greater than a 3rd of their physique weight by way of a mechanism that burns vitality, UT Southwestern Medical Heart researchers report in a brand new examine.
Revealed in Cell Metabolism, the findings spotlight the potential of GIPR—a protein regarded as a minor participant in a category of fashionable weight-loss medicine—to have its personal starring function in therapies to battle weight problems.
“Our study brings GIPR in fat cells to light as a meaningful target for the development of future therapeutic interventions for the treatment of obesity and its associated metabolic diseases,” mentioned examine chief and corresponding writer Christine M. Kusminski, Ph.D., Affiliate Professor of Inner Medication within the Touchstone Heart for Diabetes Analysis at UT Southwestern.
Based on the World Well being Group, greater than a billion folks have weight problems. This situation has been linked to an enormous variety of well being issues, together with cardiovascular ailments, kind 2 diabetes, obstructive sleep apnea, osteoarthritis, and a few varieties of most cancers.
Throughout the previous a number of years, a number of medicine that take purpose on the glucagon-like peptide-1 receptor (GLP-1R) have been authorized by the Meals and Drug Administration (FDA) to deal with weight problems. The mechanism by which these medicine exert their useful results has been well-established, with research exhibiting that they act on central areas of the mind that regulate urge for food.
Extra lately, the FDA authorized a brand new era of weight-loss medicine that target each the GLP-1R and the GIPR. Scientific trials have proven that these medicine are much more spectacular for weight reduction in people with Sort 2 diabetes and weight problems. Nonetheless, the function of GIPR in enhancing GLP-1R agonists has not been absolutely outlined.
GIP is a gut-derived incretin hormone. To raised perceive the way it impacts physique weight, Dr. Kusminski and colleagues, together with first writer Xinxin Yu, M.D., Analysis Scientist, and Philipp Scherer, Ph.D., Professor of Inner Medication and Cell Biology and Director of the Touchstone Heart, labored with mice that had fats cells genetically engineered to overproduce the GIPR.
Dr. Kusminski mentioned that after she and her crew genetically switched on the additional GIPR in fats cells, overweight mice misplaced large quantities of weight—roughly 35% inside two weeks. Moreover, when the additional receptors have been switched on in mice of regular weight, they have been proof against creating weight problems when fed a high-fat weight-reduction plan.
To discover a mechanism by which the GIPR in fats cells triggers this profound weight reduction, the researchers regarded for clues as to how gene pathways and metabolic pathways are altered in fats. They discovered that when the animals’ fats cells started overproducing GIPR, they’d elevated exercise in sarco/endoplasmic reticulum calcium ATPase (SERCA) pathways, processes that use vitality to move calcium inside cells.
A more in-depth look revealed that the additional GIPR brought about the cells to burn further ATP—a molecule used for vitality—with out transporting the calcium. This strategy of futile calcium biking burned considerably extra vitality in mice that overproduced GIPR in fats cells, thus prompting extra weight reduction.
When the researchers shut off further GIPR manufacturing after a number of weeks, the mice surprisingly didn’t regain their physique weight—they appeared to have a “metabolic memory,” which provided safety towards weight problems, even with out extra GIPR being current in fats cells, Dr. Kusminski mentioned. These findings are totally different from these in human sufferers taking current weight-loss medicine—as soon as they cease these drugs, speedy weight regain usually ensues.
“Having a better understanding of how GIPR operates in fat cells helps to explain why targeting GIPR, in addition to GLP-1R, causes individuals with obesity to lose more weight than those who take GLP-1R drugs,” Dr. Kusminski mentioned. “Furthermore, drugs that focus on the GIPR alone, or as a critical part of multi-agonist drugs, could represent a powerful approach to helping people lose weight.”
Extra data:
Xinxin Yu et al, The GIP receptor prompts futile calcium biking in white adipose tissue to extend vitality expenditure and drive weight reduction in mice, Cell Metabolism (2024). DOI: 10.1016/j.cmet.2024.11.003
Supplied by
UT Southwestern Medical Heart
Quotation:
Genetically altered fats cells in mice present promise for weight problems remedy (2025, January 6)
retrieved 7 January 2025
from https://medicalxpress.com/information/2025-01-genetically-fat-cells-mice-obesity.html
This doc is topic to copyright. Aside from any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.
